VCEL

Vericel Corp

41.02

Oct 22 • 8:03 AM ET +0.08 (0.20%)

Healthcare Biotechnology USA Mid NASD

Peers: MDXG RCEL ANIK IART MESO SNN CNMD BVS ORGO SYK

| Held by: IJR VTI IWM XBI VXF IWO IJT SPSM IBB DFAS

Index	RUT
Market Cap	2.10B
Enterprise Value	2.03B
Income	24.22M
Sales	306.30M
Book/sh	7.23
Cash/sh	3.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	398
IPO	Feb 04, 1997

P/E	88.75
Forward P/E	47.35
PEG	0.78
P/S	6.86
P/B	5.67
P/C	12.93
P/FCF	34.07
EV/EBITDA	65.25
EV/Sales	6.64
Quick Ratio	4.69
Current Ratio	5.04
Debt/Eq	0.26
LT Debt/Eq	0.22
Option/Short	Yes / Yes

EPS (ttm)	0.46
EPS next Y	0.87
EPS next Q	0.06
EPS this Y	67.19%
EPS next Y	61.92%
EPS next 5Y	61.01%
EPS past 3/5Y	- 39.20%
Sales past 3/5Y	18.90% 17.34%
EPS Y/Y TTM	228.76%
Sales Y/Y TTM	22.95%
EPS Q/Q	483.64%
Sales Q/Q	22.48%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	238.41% 6.54%

Insider Own	1.19%
Insider Trans	-15.35%
Inst Own	108.39%
Inst Trans	-2.18%
ROA	5.16%
ROE	7.16%
ROIC	5.38%
Gross Margin	74.56%
Oper. Margin	5.95%
Profit Margin	7.91%
SMA20	1.59%
SMA50	0.72%
SMA200	6.47%
Trades

Shs Outstand	51.17M
Shs Float	50.60M
Short Float	10.28%
Short Ratio	10.24
Short Interest	5.20M
52W High	49.32 -16.83%
52W Low	28.95 41.69%
Volatility	3.09% 3.24%
ATR (14)	1.21
RSI (14)	54.00
Beta	1.09
Rel Volume	0.01
Avg Volume	508.18K
Volume	172

Perf Week	0.00%
Perf Month	5.75%
Perf Quarter	-8.95%
Perf Half Y	19.24%
Perf YTD	13.91%
Perf Year	12.60%
Perf 3Y	23.59%
Perf 5Y	-20.02%
Perf 10Y	1574.29%
Recom	1.25
Target Price	59.71
Prev Close	40.94
Price	41.02
Change %	0.20%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-17-25	Downgrade	BTIG Research	Buy → Neutral
Aug-09-24	Initiated	Canaccord Genuity	Buy	$57
Jun-20-24	Initiated	TD Cowen	Buy	$55
Jan-25-24	Upgrade	Truist	Hold → Buy	$39 → $51
Aug-08-23	Upgrade	BTIG Research	Neutral → Buy	$39
Nov-10-22	Downgrade	BTIG Research	Buy → Neutral
Nov-09-22	Downgrade	Truist	Buy → Hold
Oct-14-22	Resumed	Stephens	Overweight	$40
Jan-11-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Initiated	Stephens	Overweight	$31
Sep-17-20	Initiated	Truist	Buy	$24
Oct-09-19	Initiated	H.C. Wainwright	Buy	$19
Feb-28-19	Downgrade	Needham	Buy → Hold
Aug-08-18	Reiterated	Needham	Buy	$15 → $14
Jul-16-18	Upgrade	Ladenburg Thalmann	Neutral → Buy
Apr-04-18	Initiated	Leerink Partners	Outperform	$15
Mar-06-18	Reiterated	Needham	Buy	$5 → $15
Mar-06-18	Downgrade	Ladenburg Thalmann	Buy → Neutral
Mar-05-18	Reiterated	BTIG Research	Buy	$8 → $13
Jun-21-17	Initiated	BTIG Research	Buy	$6

Show Previous Ratings

Today 08:30AM	Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire)
Sep-22-26 08:09AM	Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) (FinanceWire)
Sep-08-26 08:30AM	Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026 (GlobeNewswire)
Aug-03-26 10:55AM	Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison (IPO-Edge.com)
Jul-30-26 07:55AM	Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program (GlobeNewswire)
08:32AM	Loading…
Jul-16-26 08:32AM	Why is Cathie Wood's ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD) (FinanceWire)
08:30AM	Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026 (GlobeNewswire)
Jul-02-26 08:48AM	Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD) (FinanceWire)
Jun-09-26 08:30AM	Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026 (GlobeNewswire)
May-07-26 07:45AM	Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance (GlobeNewswire)
Apr-23-26 08:30AM	Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-02-26 02:40PM	Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid (GlobeNewswire)
Mar-09-26 08:31PM	Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI (Insider Monkey)
Mar-04-26 08:00AM	Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility (GlobeNewswire)
Mar-03-26 08:30AM	Vericel to Present at Multiple Upcoming Investor Conferences (GlobeNewswire)
08:05PM	Loading…
Feb-28-26 08:05PM	MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference (MarketBeat)
Feb-27-26 12:39PM	Vericel Q4 Earnings Call Highlights (MarketBeat) -5.31%
Feb-26-26 08:09PM	Vericel Corporation Q4 2025 Earnings Call Summary (Moby)
04:11PM	Vericel Corp (VCEL) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
12:15PM	Vericel Corporation (VCEL) Matches Q4 Earnings Estimates (Zacks)
07:55AM	Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results (GlobeNewswire)
Feb-12-26 08:30AM	Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Jan-13-26 12:57PM	Why Is Vericel Stock Gaining Tuesday? (Benzinga)
09:00AM	Vericel Announces Preliminary 2025 Financial Results and Business Updates (GlobeNewswire)
Jan-06-26 08:30AM	Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 (GlobeNewswire) +6.09%
Dec-21-25 09:57AM	Truist Slashes PT on Vericel Corporation (VCEL) to $45 From $50 (Insider Monkey)
Nov-14-25 08:30AM	Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 (GlobeNewswire)
Nov-10-25 09:55AM	Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade (Zacks)
Nov-06-25 04:01PM	Vericel Corp (VCEL) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
09:10AM	Vericel Corporation (VCEL) Q3 Earnings and Revenues Top Estimates (Zacks)
07:55AM	Loading…
07:55AM	Vericel Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-31-25 09:15AM	Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out? (Zacks)
Oct-23-25 08:30AM	Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025 (GlobeNewswire)
Oct-22-25 08:48AM	Here's Why Vericel Corporation (VCEL) Underperformed in Q3 (Insider Monkey)
Oct-20-25 11:08PM	Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46 (Insider Monkey)
Sep-12-25 08:53AM	Here's Why Vericel Corp. (VCEL) Traded Down in Q2 (Insider Monkey)
Sep-11-25 03:46PM	Is the Options Market Predicting a Spike in Vericel Stock? (Zacks) +7.09%
Aug-28-25 08:30AM	Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025 (GlobeNewswire)
Aug-20-25 12:13AM	Leerink Partners Raises the PT Vericel (VCEL), Maintains a Buy Rating (Insider Monkey)
Jul-31-25 09:15AM	Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -14.07%
08:08AM	Vericel Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-30-25 09:44AM	Earnings To Watch: Vericel Corp (VCEL) Reports Q2 2025 Result (GuruFocus.com)
09:00AM	Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-24-25 09:47AM	Vericel Corporation (VCEL): A Bull Case Theory (Insider Monkey)
Jul-17-25 08:30AM	Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 (GlobeNewswire)
Jun-10-25 08:30AM	Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 (GlobeNewswire)
May-09-25 03:13AM	Vericel Corp (VCEL) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
May-08-25 09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:45AM	Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling (Insider Monkey)
07:55AM	Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance (GlobeNewswire)
May-07-25 02:18PM	Vericel Q1 2025 Earnings Preview (Seeking Alpha) +5.25%
10:08AM	Earnings To Watch: Vericel Corp (VCEL) Reports Q1 2025 Result (GuruFocus.com)
08:30AM	Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 (GlobeNewswire)
May-06-25 05:35PM	Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
May-01-25 05:15PM	Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-30-25 08:39AM	Vericel Corp. (VCEL) Faces Challenges as Burn Care Revenue Wanes and MACI Growth Remains Uncertain (Insider Monkey)
Apr-24-25 08:30AM	Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Mar-04-25 08:30AM	Vericel to Present at Multiple Upcoming Investor Conferences (GlobeNewswire)
Feb-28-25 02:11AM	Vericel Corp (VCEL) Q4 2024 Earnings Call Highlights: Record Revenue and Strong Growth Trajectory (GuruFocus.com)
01:51AM	Q4 2024 Vericel Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-27-25 09:05AM	Vericel Corporation (VCEL) Tops Q4 Earnings Estimates (Zacks) -6.11%
07:54AM	Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results (GlobeNewswire)
Feb-26-25 07:28AM	Earnings To Watch: Vericel Corp (VCEL) Reports Q4 2024 Result (GuruFocus.com)
Feb-13-25 08:30AM	Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025 (GlobeNewswire)
Jan-14-25 04:05PM	Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets (GlobeNewswire)
Jan-08-25 08:30AM	Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 (GlobeNewswire)
Dec-19-24 07:36AM	Vericel price target raised to $67 from $61 at Truist (TipRanks)
Nov-11-24 02:06PM	Vericel Stock Sees RS Rating Shoot Higher (Investor's Business Daily) +5.15%
Nov-08-24 04:03AM	Vericel Corp (VCEL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic FDA ... (GuruFocus.com) +7.94%
Nov-07-24 09:10AM	Vericel Corporation (VCEL) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:55AM	Vericel Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:15AM	Vericel Corp (VCEL) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com) +7.35%
Oct-24-24 08:30AM	Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-22-24 09:31AM	Vericel Corp. (VCEL) Cooled Down in Q3 After a 20% Rise in the First Half (Insider Monkey)
Oct-18-24 03:04PM	State Street Corp's Strategic Reduction in Vericel Corp Holdings (GuruFocus.com)
Oct-09-24 03:44PM	Vericel Corp (VCEL) Q2 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
Aug-29-24 09:17AM	Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024 (GlobeNewswire)
Aug-26-24 07:45AM	Vericel Announces FDA Approval and Commercial Availability of MACI Arthro (GlobeNewswire)
Aug-16-24 10:33AM	MediWound and Vericel win FDA paediatric label expansion for NexoBrid (Medical Device Network)
Aug-15-24 04:05PM	Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns (GlobeNewswire)
Aug-07-24 08:30AM	Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024 (GlobeNewswire)
Aug-05-24 12:00PM	What Makes Vericel (VCEL) a New Strong Buy Stock (Zacks)
Aug-01-24 09:05AM	Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.94%
07:55AM	Vericel Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 03:45PM	AppFolio, Inc. (APPF): One of Ray Dalio's Top 10 Growth Stock Picks Right Now? (Insider Monkey)
Jul-22-24 08:30AM	Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer (GlobeNewswire)
Jul-18-24 08:30AM	Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024 (GlobeNewswire)
Jul-16-24 07:01PM	Insider Sale: CFO Mara Joseph Anthony Jr Sells 5,000 Shares of Vericel Corp (VCEL) (GuruFocus.com)
Jul-02-24 09:58AM	Should You Consider Adding Vericel Corporation (VCEL) to Your Portfolio? (Insider Monkey)
Jun-27-24 02:03PM	The 3 Highest-Rated Medical Stocks You Can Buy Today (InvestorPlace)
Jun-25-24 07:22AM	Factors Behind Vericel Corporation (VCEL) Stock's Positive Momentum (Insider Monkey)
Jun-20-24 09:54AM	Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls (The Fly)
Jun-11-24 08:30AM	Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 (GlobeNewswire)
May-22-24 08:30AM	Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 (GlobeNewswire)
May-21-24 06:42AM	Multiple Factors Pushed Vericel Corp. (VCEL) in Q1 (Insider Monkey)
May-09-24 03:28PM	Vericel Corporation (NASDAQ:VCEL) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:08AM	Vericel Corp (VCEL) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and ... (GuruFocus.com)
May-08-24 11:24PM	Q1 2024 Vericel Corp Earnings Call (Thomson Reuters StreetEvents)
09:35AM	Vericel Corp (VCEL) Surpasses Q1 Revenue Forecasts with Strong Growth in Core Markets (GuruFocus.com)
09:10AM	Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell (MT Newswires)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MCLAUGHLIN KEVIN F	Director	Aug 12 '26	Option Exercise	13.05	7,000	91,350	25,300	Aug 14 04:05 PM
MCLAUGHLIN KEVIN F	Director	Aug 12 '26	Sale	44.53	7,000	311,710	18,300	Aug 14 04:05 PM
MCLAUGHLIN KEVIN F	Director	Aug 12 '26	Proposed Sale	44.11	7,000	308,770		Aug 12 09:47 AM
Halpin Michael	Chief Operating Officer	Aug 03 '26	Option Exercise	16.66	10,000	166,600	26,394	Aug 05 04:05 PM
Halpin Michael	Chief Operating Officer	Aug 03 '26	Sale	46.84	10,000	468,400	16,394	Aug 05 04:05 PM
Halpin Michael	Officer	Aug 03 '26	Proposed Sale	45.98	10,000	459,800		Aug 03 12:43 PM
SIEGAL JONATHAN	Principal Accounting Officer	Jul 30 '26	Option Exercise	31.51	4,500	141,810	3,578	Jul 31 04:05 PM
SIEGAL JONATHAN	Principal Accounting Officer	Jul 30 '26	Sale	48.90	4,500	220,050	1,078	Jul 31 04:05 PM
SIEGAL JONATHAN	Officer	Jul 30 '26	Proposed Sale	48.90	4,500	220,050		Jul 30 10:56 AM
SIEGAL JONATHAN	Principal Accounting Officer	Jun 26 '26	Option Exercise	29.82	2,500	74,550	3,386	Jun 30 04:05 PM
SIEGAL JONATHAN	Principal Accounting Officer	Jun 26 '26	Sale	44.90	2,732	122,667	886	Jun 30 04:05 PM
Mara Joseph Anthony Jr	Chief Financial Officer	Jun 26 '26	Sale	44.75	5,000	223,750	16,009	Jun 30 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Jun 26 '26	Option Exercise	29.82	10,000	298,200	80,753	Jun 30 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Jun 26 '26	Sale	45.00	10,000	450,000	75,753	Jun 30 04:05 PM
Flynn Sean C.	Chief Legal Officer	Jun 26 '26	Option Exercise	16.25	15,000	243,750	16,647	Jun 30 04:05 PM
Flynn Sean C.	Chief Legal Officer	Jun 26 '26	Sale	45.64	15,000	684,600	1,647	Jun 30 04:05 PM
Flynn Sean C.	Officer	Jun 26 '26	Proposed Sale	45.64	15,000	684,659		Jun 26 04:21 PM
Mara Joseph Anthony Jr	Officer	Jun 26 '26	Proposed Sale	44.75	5,000	223,750		Jun 26 04:12 PM
SIEGAL JONATHAN	Officer	Jun 26 '26	Proposed Sale	44.90	2,732	122,667		Jun 26 04:02 PM
Hopper Jonathan Mark	Officer	Jun 26 '26	Proposed Sale	45.00	10,000	450,000		Jun 26 03:55 PM
Halpin Michael	Chief Operating Officer	Jun 18 '26	Option Exercise	16.66	10,000	166,600	26,248	Jun 22 04:05 PM
Halpin Michael	Chief Operating Officer	Jun 18 '26	Sale	40.24	10,000	402,400	16,248	Jun 22 04:05 PM
Flynn Sean C.	Chief Legal Officer	Jun 18 '26	Option Exercise	16.25	15,000	243,750	16,647	Jun 22 04:05 PM
Flynn Sean C.	Chief Legal Officer	Jun 18 '26	Sale	40.21	15,000	603,150	1,647	Jun 22 04:05 PM
Flynn Sean C.	Officer	Jun 18 '26	Proposed Sale	40.21	15,000	603,148		Jun 18 04:26 PM
Halpin Michael	Officer	Jun 18 '26	Proposed Sale	40.24	10,000	402,401		Jun 18 04:11 PM
Hopper Jonathan Mark	Chief Medical Officer	Jun 02 '26	Option Exercise	16.66	4,375	72,888	80,128	Jun 04 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Jun 02 '26	Sale	35.00	4,375	153,125	75,753	Jun 04 04:05 PM
Hopper Jonathan Mark	Officer	Jun 02 '26	Proposed Sale	35.00	4,375	153,125		Jun 02 02:40 PM
MCLAUGHLIN KEVIN F	Director	May 13 '26	Option Exercise	7.84	7,000	54,880	21,800	May 15 04:06 PM
MCLAUGHLIN KEVIN F	Director	May 13 '26	Sale	32.83	7,000	229,775	18,300	May 15 04:06 PM
Wotton Paul K	Director	May 11 '26	Sale	32.74	10,000	327,425	18,802	May 13 04:05 PM
MCLAUGHLIN KEVIN F	Director	May 13 '26	Proposed Sale	32.57	7,000	227,990		May 13 02:16 PM
Wotton Paul K	Director	May 11 '26	Proposed Sale	32.74	10,000	327,425		May 11 02:32 PM
Mara Joseph Anthony Jr	Chief Financial Officer	May 07 '26	Sale	40.50	5,000	202,500	21,009	May 08 04:05 PM
SIEGAL JONATHAN	Principal Accounting Officer	May 06 '26	Sale	38.00	3,433	130,454	2,540	May 08 04:05 PM
SIEGAL JONATHAN	Principal Accounting Officer	May 07 '26	Sale	40.50	1,422	57,591	1,118	May 08 04:05 PM
SIEGAL JONATHAN	Officer	May 07 '26	Proposed Sale	40.50	1,422	57,591		May 07 12:36 PM
Mara Joseph Anthony Jr	Officer	May 07 '26	Proposed Sale	40.50	5,000	202,500		May 07 12:02 PM
SIEGAL JONATHAN	Officer	May 06 '26	Proposed Sale	38.00	3,433	130,454		May 06 03:30 PM
Hopper Jonathan Mark	Chief Medical Officer	Apr 02 '26	Option Exercise	10.95	3,472	38,018	79,028	Apr 06 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Apr 02 '26	Sale	35.00	3,472	121,520	75,556	Apr 06 04:05 PM
Hopper Jonathan Mark	Officer	Apr 02 '26	Proposed Sale	35.00	3,472	121,520		Apr 02 02:28 PM
Rubino Alan L	Director	Mar 25 '26	Option Exercise	2.76	15,000	41,400	60,994	Mar 27 04:05 PM
Hagen Heidi	Director	Mar 23 '26	Option Exercise	2.76	15,000	41,400	46,850	Mar 25 04:05 PM
Hagen Heidi	Director	Mar 23 '26	Sale	32.41	15,000	486,150	31,850	Mar 25 04:05 PM
Hagen Heidi	Director	Mar 23 '26	Proposed Sale	32.41	15,000	486,163		Mar 23 04:08 PM
Flynn Sean C.	Chief Legal Officer	Mar 02 '26	Option Exercise	16.25	15,000	243,750	16,262	Mar 04 04:05 PM
Flynn Sean C.	Chief Legal Officer	Mar 02 '26	Sale	35.18	21,421	753,530	1,262	Mar 04 04:05 PM
Halpin Michael	Chief Operating Officer	Mar 02 '26	Sale	35.30	10,305	363,766	16,080	Mar 04 04:05 PM
Flynn Sean C.	Officer	Mar 02 '26	Proposed Sale	35.18	21,421	753,509		Mar 02 04:54 PM
Halpin Michael	Officer	Mar 02 '26	Proposed Sale	35.30	10,305	363,749		Mar 02 04:21 PM
Colangelo Dominick	President and CEO	Feb 24 '26	Option Exercise	0.00	18,250	0	321,270	Feb 26 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Feb 24 '26	Option Exercise	0.00	4,650	0	76,192	Feb 26 04:05 PM
SIEGAL JONATHAN	Principal Accounting Officer	Feb 24 '26	Option Exercise	0.00	3,415	0	6,585	Feb 26 04:05 PM
Mara Joseph Anthony Jr	Chief Financial Officer	Feb 24 '26	Option Exercise	0.00	9,250	0	27,262	Feb 26 04:05 PM
Halpin Michael	Chief Operating Officer	Feb 24 '26	Option Exercise	0.00	10,500	0	28,871	Feb 26 04:05 PM
Flynn Sean C.	Chief Legal Officer	Feb 24 '26	Option Exercise	0.00	6,500	0	9,014	Feb 26 04:05 PM
Colangelo Dominick	President and CEO	Feb 18 '26	Option Exercise	0.00	11,700	0	290,427	Feb 20 04:06 PM
Flynn Sean C.	Chief Legal Officer	Feb 18 '26	Option Exercise	0.00	5,325	0	5,097	Feb 20 04:06 PM
Hopper Jonathan Mark	Chief Medical Officer	Feb 18 '26	Option Exercise	0.00	2,325	0	72,009	Feb 20 04:06 PM
Mara Joseph Anthony Jr	Chief Financial Officer	Feb 18 '26	Option Exercise	0.00	7,380	0	20,179	Feb 20 04:06 PM
SIEGAL JONATHAN	Principal Accounting Officer	Feb 18 '26	Option Exercise	0.00	2,920	0	4,682	Feb 20 04:06 PM
Halpin Michael	Chief Operating Officer	Feb 18 '26	Option Exercise	0.00	9,075	0	22,669	Feb 20 04:06 PM
MCLAUGHLIN KEVIN F	Director	Feb 11 '26	Option Exercise	2.63	7,000	18,410	22,100	Feb 13 04:05 PM
MCLAUGHLIN KEVIN F	Director	Feb 11 '26	Sale	34.66	7,000	242,620	15,100	Feb 13 04:05 PM
MCLAUGHLIN KEVIN F	Director	Feb 11 '26	Proposed Sale	35.62	7,000	249,340		Feb 11 10:07 AM
Halpin Michael	Chief Operating Officer	Jan 07 '26	Option Exercise	16.66	10,000	166,600	26,080	Jan 09 04:05 PM
Halpin Michael	Chief Operating Officer	Jan 07 '26	Sale	40.48	10,000	404,800	16,080	Jan 09 04:05 PM
Halpin Michael	Officer	Jan 07 '26	Proposed Sale	40.48	10,000	404,833		Jan 07 04:22 PM
Hopper Jonathan Mark	Chief Medical Officer	Dec 02 '25	Option Exercise	18.00	1,652	29,736	68,214	Dec 04 04:05 PM
Hopper Jonathan Mark	Chief Medical Officer	Dec 02 '25	Sale	39.14	1,652	64,659	66,562	Dec 04 04:05 PM
Wotton Paul K	Director	Dec 02 '25	Sale	37.97	2,500	94,925	28,102	Dec 04 04:05 PM
Wotton Paul K	Director	Dec 03 '25	Sale	37.83	2,500	94,575	25,602	Dec 04 04:05 PM
Wotton Paul K	Director	Dec 03 '25	Proposed Sale	37.83	2,500	94,575		Dec 03 11:25 AM
Wotton Paul K	Director	Dec 02 '25	Proposed Sale	37.97	2,500	94,919		Dec 02 04:08 PM
Hopper Jonathan Mark	Officer	Dec 02 '25	Proposed Sale	39.14	1,652	64,659		Dec 02 10:10 AM
Halpin Michael	Chief Operating Officer	Nov 11 '25	Option Exercise	16.66	2,642	44,016	18,574	Nov 13 04:05 PM
Halpin Michael	Chief Operating Officer	Nov 11 '25	Sale	40.41	2,642	106,763	15,932	Nov 13 04:05 PM
MCLAUGHLIN KEVIN F	Director	Nov 10 '25	Option Exercise	2.63	7,000	18,410	22,100	Nov 12 04:06 PM
MCLAUGHLIN KEVIN F	Director	Nov 10 '25	Sale	38.59	7,000	270,130	15,100	Nov 12 04:06 PM
Halpin Michael	Officer	Nov 11 '25	Proposed Sale	40.41	2,642	106,760		Nov 12 07:33 AM
Halpin Michael	Chief Operating Officer	Nov 06 '25	Option Exercise	16.66	7,358	122,584	23,290	Nov 10 04:05 PM
Halpin Michael	Chief Operating Officer	Nov 06 '25	Sale	40.47	7,358	297,778	15,932	Nov 10 04:05 PM
MCLAUGHLIN KEVIN F	Director	Nov 10 '25	Proposed Sale	39.71	7,000	277,970		Nov 10 02:47 PM
Halpin Michael	Officer	Nov 06 '25	Proposed Sale	40.47	7,358	297,775		Nov 06 04:19 PM

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

CEOMr. Dominick C. Colangelo Esq.

CFO & TreasurerMr. Joseph Anthony Mara Jr.

Chief Operating OfficerMr. Michael Halpin

Chief Legal OfficerMr. Sean C. Flynn

M.B. Ch.B.Dr. Jonathan M. Hopper FRCSEd.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VCEL

Vericel Corp

Upgrade your Finviz experience